U.S. market Closed. Opens in 1 hour 10 minutes

OCUP | Ocuphire Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue19.05M39.85M589.00KN/AN/AN/A
Cost of Revenue6.00K4.00K4.00K8.00K3.00KN/A
Gross Profit19.04M39.85M585.00K-8.00K-3.00KN/A
Operating Expenses29.61M21.62M23.29M9.47M4.19M20.54M
Selling, General & Admin11.95M7.27M8.12M2.82M1.82M7.43M
Research & Development17.65M14.36M15.17M6.65M2.37M13.11M
Other Operating Expenses1.84M-14.00K-157.00K9.00K-68.00KN/A
Operating Income-10.56M18.23M-22.70M-19.97M-4.19M-20.54M
Other Expenses / Income589.00K-23.00K-33.99M-4.65M-1.98M6.17M
Before Tax Income-9.97M18.20M-56.69M-24.62M-6.17M-14.37M
Income Tax Expenses12.00K315.00K-159.00K6.86M1.34MN/A
Net Income-9.99M17.89M-56.53M-31.48M-7.51M-14.37M
Interest ExpensesN/A9.00K2.00K6.85M1.41MN/A
Basic Shares Outstanding21.59M19.93M14.85M4.66M711.21K32.92M
Diluted Shares Outstanding21.59M20.60M14.85M4.66M711.21K32.92M
EBITDA-10.56M18.21M-22.86M-9.45M-4.26M-20.54M
EBITDA Margin-55.42%45.70%-3,881.49%0.00%0.00%0.00%
EBIT-9.97M18.21M-56.69M-17.77M-4.76M-14.37M
EBIT Margin-52.36%45.70%-9,624.96%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙